Ginkgo Bioworks DNA Reportable Segment — G&A
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Ginkgo Bioworks in its filing.
Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.
The official record: Ginkgo Bioworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ginkgo Bioworks's reportable segment — g&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Ginkgo Bioworks's reportable segment — G&A?
- Ginkgo Bioworks (DNA) reported reportable segment — G&A of $12.72M in Q1 2026.
- What does reportable segment — G&A mean?
- This encompasses the overhead and support costs required to manage the operations of a specific business segment, excluding direct production or R&D expenses. Tracking this provides insight into the segment's operational leverage and the efficiency of its management structure.